title: eComment: Controversies on the antiplatelet therapy before coronary artery bypass grafting surgery.
authors.affiliation: Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey.
authors.forename: Rafet
authors.initials: R
authors.lastname: Gunay
authors.forename: Yavuz
authors.initials: Y
authors.lastname: Sensoz
authors.forename: Ilyas
authors.initials: I
authors.lastname: Kayacioglu
authors.forename: Mahmut M
authors.initials: MM
authors.lastname: Demirtas
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D001803:Blood Transfusion; D002315:Cardiopulmonary Bypass; D000077144:Clopidogrel; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D018570:Risk Assessment; D012307:Risk Factors; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin